Dylan Thibault

Journal Article BMC Public Health · September 30, 2025 BACKGROUND: The 2022 mpox outbreak in the United States primarily affected sexual minority men. Barrier to healthcare access, treatment, and vaccination against mpox are not well characterized. Stigma surrounding mpox has not been well quantified, and may ... Full text Link to item Cite

Impact of Anticholinergic Burden and Clinical-Demographic Characteristics on Incident Dementia in Parkinson Disease.

Journal Article Journal of geriatric psychiatry and neurology · July 2025 PurposeAnticholinergic medication use measured via the Anticholinergic Cognitive Burden (ACB) scale has been associated with an increased dementia incidence in older adults but has not been explored specifically for Parkinson disease dementia (PDD). We use ... Full text Cite

Comparing retrospective informant assessments to prospectively collected cognitive measures in the Health and Retirement Study

Journal Article Alzheimer S and Dementia Diagnosis Assessment and Disease Monitoring · July 1, 2025 INTRODUCTION: Clinicians and researchers frequently ask informants about changes in a person's cognition, but whether informant assessments correspond to objectively measured change is unclear. METHODS: A subset (n = 2710) of US Health and Retirement Study ... Full text Cite

View All Publications

Dylan Thibault

Current Appointments & Affiliations

Recent Publications

Mpox epidemiology, barriers to treatment and prevention, and perceived stigma: a cross-sectional study.

Impact of Anticholinergic Burden and Clinical-Demographic Characteristics on Incident Dementia in Parkinson Disease.

Comparing retrospective informant assessments to prospectively collected cognitive measures in the Health and Retirement Study

Recent Grants

Comparative Effectiveness of Emerging Medications in Children with Inflammatory Bowel Disease

Urinary Stone Research_USDRN-SDRC Grant_Continuation

Urinary Stone Research_USDRN-SDRC Grant_Continuation